Shree Ganesh Remedies Ltd

Shree Ganesh Rem Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Shree Ganesh Remedies Ltd

₹ 669 -0.20%
22 Nov 4:00 p.m.
ganeshremedies.com BSE: 540737
About

Shree Ganesh Remedies is engaged in chemical
manufacturing, specialising in pharmaceutical
intermediates and speciality chemicals.[1]

Key Points

Evolution of Business[1]
The company is changing its focus from Intermediates for Off-patent and generic drugs towards patented molecules requiring strong technical know how. The revenue contribution from Intermediates has also shifted from 90% to <60%.

Website BSE
  • Market Cap ₹ 859 Cr.
  • Current Price ₹ 669
  • High / Low ₹ 950 / 558
  • Stock P/E 30.6
  • Book Value ₹ 104
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 35.1% CAGR over last 5 years
  • Promoter holding has increased by 1.17% over last quarter.

Cons

  • Stock is trading at 6.45 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2020 Dec 2020 Jun 2021 Sep 2021 Dec 2021 Mar 2024 Jun 2024 Sep 2024
11.52 13.26 12.63 16.97 21.13 37.33 24.78 32.33
7.31 10.08 9.58 12.52 15.36 20.39 16.65 21.02
Operating Profit 4.21 3.18 3.05 4.45 5.77 16.94 8.13 11.31
OPM % 36.55% 23.98% 24.15% 26.22% 27.31% 45.38% 32.81% 34.98%
0.45 0.54 1.11 0.44 0.88 1.32 0.54 0.19
Interest 0.01 0.02 0.07 0.03 0.03 0.16 0.32 0.44
Depreciation 0.64 0.22 0.82 0.95 0.99 1.86 2.02 2.42
Profit before tax 4.01 3.48 3.27 3.91 5.63 16.24 6.33 8.64
Tax % 22.94% 20.40% 28.75% 22.76% 25.40% 22.48% 26.70% 25.81%
3.09 2.77 2.34 3.02 4.20 12.58 4.65 6.41
EPS in Rs 2.41 2.16 1.83 2.36 3.28 9.83 3.62 4.99
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2024
35 64 49 126
26 52 35 84
Operating Profit 9 13 14 42
OPM % 25% 20% 28% 33%
1 4 2 3
Interest 0 1 0 1
Depreciation 1 2 3 6
Profit before tax 9 14 13 38
Tax % 28% 23% 25% 26%
6 10 10 28
EPS in Rs 4.88 8.18 7.62 21.96
Dividend Payout % 18% 13% 18% 2%
Compounded Sales Growth
10 Years: %
5 Years: 29%
3 Years: 37%
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: 35%
3 Years: 42%
TTM: %
Stock Price CAGR
10 Years: %
5 Years: 62%
3 Years: 26%
1 Year: 10%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2024 Sep 2024
Equity Capital 9 9 13 13
Reserves 25 33 109 120
1 4 36 34
7 9 12 11
Total Liabilities 41 55 171 178
14 20 81 97
CWIP 0 0 17 3
Investments 4 3 5 7
23 32 69 72
Total Assets 41 55 171 178

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2024
-5 5 3 30
-0 -3 -1 -33
-0 -0 -1 10
Net Cash Flow -5 1 2 7

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2019 Mar 2020 Mar 2021 Mar 2024
Debtor Days 101 101 59
Inventory Days 125 61 156
Days Payable 75 43 51
Cash Conversion Cycle 151 119 164
Working Capital Days 149 115 110
ROCE % 35%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
69.12% 69.12% 69.12% 68.27% 68.27% 69.34% 69.34% 69.33% 69.33% 69.33% 69.33% 70.49%
0.02% 0.02% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.01% 0.01%
30.86% 30.86% 30.88% 31.73% 31.72% 30.67% 30.66% 30.67% 30.66% 30.67% 30.66% 29.50%
No. of Shareholders 5,7415,7455,4655,8436,4726,7476,4077,3307,5187,0497,1868,508

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Concalls